← Back to Search

Procedure

1 for Ultrasound

N/A
Waitlist Available
Led By Kevin M. Kelly, M.D.
Research Sponsored by SonoCine, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to determine whether addition of automated whole breast ultrasound to the usual screening mammography in a population of asymptomatic women with mammographically dense breasts will result in a significantly greater number of breast cancers discovered than would be found by mammography alone.

Eligible Conditions
  • Ultrasound
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Adjunct screening with sonocine

Find a Location

Who is running the clinical trial?

SonoCine, Inc.Lead Sponsor
Kevin M. Kelly, M.D.Principal InvestigatorSonoCine, Inc.
~204 spots leftby Oct 2025